In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Insulet Corporation

https://www.insulet.com/

Latest From Insulet Corporation

Analysts Are Bullish On Insulet’s Omnipod 5 For Managing Type 1 Diabetes

A trial of Insulet’s Omnipod 5 trial in children and adults showed improvements in time and range and hemoglobin A1c after three months of use compared to standard therapy.

Clinical Trials Commercial

Glooko Raises $30M To Accelerate Commercial Strategy, R&D, Tuck-In Acquisitions

Glooko will use the proceeds to expand into new geographies and take advantage of rising reimbursement for digital health, expand solutions for co-morbid conditions, and explore tuck-in acquisitions.

Telehealth Digital Health

Market Intel: Rivalry Among Insulin Pump Makers Heats Up With Expected Launches In 2021

The global insulin pump market is expected to see double-digit growth, reaching $5.1bn in 2024, with product launches expected by Medtronic, Insulet, Tandem and smaller players in 2021. 

Market Intelligence Diabetic Care

JPM 2021: Boston Scientific, Abbott, Dexcom, Insulet, Silk Road Medical

The annual J.P. Morgan Healthcare Conference includes presentations from many major medtech companies outlining their growth strategies and expectations for 2021. Here are some of the highlights from the second day of the meeting.

Financing Launches
See All

Company Information

  • Industry
  • Medical Devices
  • Other Names / Subsidiaries
    • Insulet Canada Corporation
    • Neighborhood Diabetes
    • Neighborhood Holdings, Inc.
UsernamePublicRestriction

Register